North America continues to play a pivotal role in the growth of the Viral Clearance Market, supported by its advanced biopharmaceutical industry, strong research infrastructure, and increasing investments in biologics development. The region remains a key hub for biotechnology innovation, with pharmaceutical and biopharmaceutical companies focusing on ensuring product safety and regulatory...